Vertex Pharmaceuticals Inc (VRTX)

397.27 +0.63 (+0.16%) USD  |  NASDAQ  |  Dec 20, 16:00
395.00 -2.27 (-0.57%) After-Hours: 20:00
More

Vertex Pharmaceuticals Debt to Equity Ratio: 0.00 for Sept. 30, 2024

Debt to Equity Ratio Chart

View Debt to Equity Ratio for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition
Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Eli Lilly and Co 2.185
Gilead Sciences Inc 1.258
Bristol-Myers Squibb Co 2.902
Pfizer Inc 0.7219
PTC Therapeutics Inc -0.2704

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 22.24B
Total Liabilities (Quarterly) 6.609B
Shareholders Equity (Quarterly) 15.63B
Current Ratio 2.468